WASHINGTON (AP) -- A bipartisan group of lawmakers revived a proposal
Wednesday that would allow generic drug companies to market cheaper versions
of biotech pharmaceuticals -- some of the most advanced and expensive
medicines on the market.
Generic drug companies such as Teva Pharmaceutical Industries and Barr
Pharmaceuticals Inc. have thrived over the past 20 years by releasing
generic versions of traditional drugs once they lose patent protection. But
in the past decade they have sought the a
